camptothecin has been researched along with Thyroid Carcinoma, Anaplastic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Astvatsaturyan, K; Fan, X; Lai, J; Peralta-Venturina, M; Seok, JY | 1 |
| Annaratone, L; Argenziano, M; Barrera, G; Boggio, E; Boldorini, R; Cavalli, R; Chiocchetti, A; Clemente, N; Dianzani, C; Dianzani, U; Fantozzi, R; Ferrara, B; Gigliotti, CL; Giovarelli, M; Marchiò, C; Occhipinti, S; Pizzimenti, S; Trotta, F | 1 |
| Alì, G; Antonelli, A; Basolo, F; Bocci, G; Di Desidero, T; Ferrari, SM; Fioravanti, A; Fontanini, G; Francia, G; Orlandi, P | 1 |
3 other study(ies) available for camptothecin and Thyroid Carcinoma, Anaplastic
| Article | Year |
|---|---|
TROP-2, 5hmC, and IDH1 Expression in Anaplastic Thyroid Carcinoma.
Topics: 5-Methylcytosine; Antibodies, Monoclonal, Humanized; Antigens, Neoplasm; Biomarkers, Tumor; Camptothecin; Cell Adhesion Molecules; Feasibility Studies; Humans; Immunoconjugates; Immunohistochemistry; Isocitrate Dehydrogenase; Molecular Targeted Therapy; Mutation; Patient Selection; Predictive Value of Tests; Prognosis; Thyroid Carcinoma, Anaplastic; Thyroid Gland; Thyroid Neoplasms | 2021 |
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors.
Topics: Animals; Camptothecin; Cell Line, Tumor; Heterografts; Humans; Male; Mice; Mice, SCID; Thyroid Carcinoma, Anaplastic | 2017 |
Synergistic efficacy of irinotecan and sunitinib combination in preclinical models of anaplastic thyroid cancer.
Topics: Aged; Animals; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Line, Tumor; Drug Synergism; Female; Humans; Indoles; Irinotecan; Male; Mice; Mice, Nude; Pyrroles; Sunitinib; Thyroid Carcinoma, Anaplastic | 2017 |